These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8056691)

  • 1. Use of cefotaxime or ceftazidime susceptibility tests for predicting susceptibility of Enterobacteriaceae and Pseudomonas aeruginosa.
    Heym B; Lacroix O; Péan Y; Gertner J; Nicolas MH; Jarlier V
    J Antimicrob Chemother; 1994 Apr; 33(4):729-35. PubMed ID: 8056691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aztreonam: antibacterial activity, beta-lactamase stability, and interpretive standards and quality control guidelines for disk-diffusion susceptibility tests.
    Barry AL; Thornsberry C; Jones RN; Gavan TL
    Rev Infect Dis; 1985; 7 Suppl 4():S594-604. PubMed ID: 3909316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative in vitro activity of 2 monobactams (RO 172301 (AMA 1080)and aztreonam), ceftazidime and cefotaxime on Gram-negative bacilli].
    Thabaut A; Meyran M; Huerre M
    Pathol Biol (Paris); 1985 May; 33(5):404-7. PubMed ID: 3929217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [in vitro activity of carbapenems against Enterobacteriaceae and Pseudomonas aeruginosa hyperproducers of group 1 chromosomal beta-lactamases].
    Martínez-Beltrán J; Calderón C; Sierra MP; Alvarez M; Cantón R
    Enferm Infecc Microbiol Clin; 1997 Sep; 15 Suppl 1():20-6. PubMed ID: 9410065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibiotic susceptibility and occurrence of ESBL in Pseudomonas aeruginosa strains isolated from different clinical specimens].
    Sacha PT; Jakoniuk P; Wieczorek P; Zalewska M; Leszczyńska K
    Med Dosw Mikrobiol; 2004; 56(3):263-73. PubMed ID: 15773503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of piperacillin, ticarcillin, mezlocillin, ticarcillin-clavulanic acid, aztreonam, ceftazidime, azlocillin, cefoperazone, and thienamycin against Pseudomonas aeruginosa.
    Greenberg RN; Bollinger MR; Alivisatos MR
    Clin Ther; 1986; 8(6):655-7. PubMed ID: 3098426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of different phenotypic methods detecting extended spectrum beta-lactamases in Pseudomonas aeruginosa and Acinetobacter baumannii strains].
    Zarakolu P; Metan G; Hasçelik G; Akova M
    Mikrobiyol Bul; 2005 Jul; 39(3):265-72. PubMed ID: 16358485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-lactamase-mediated resistance to extended spectrum cephalosporins among clinical isolates of Pseudomonas aeruginosa.
    Ben-Mahrez K; Rejiba S; Belhadj C; Belhadj O
    Res Microbiol; 1999; 150(6):403-6. PubMed ID: 10466408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in vitro antibacterial activity of aztreonam against clinical isolates of gram-negative bacteria.
    Shibl AM; Ishag AH; Durgham SM
    Chemotherapy; 1989; 35 Suppl 1():72-6. PubMed ID: 2659292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfer of antibiotic resistance and production of extended-spectrum beta-lactamase (ESBL) in nosocomial Klebsiella pneumoniae strains from two hospitals in Czech Republic.
    Blahová J; Králiková K; Krcméry V; Torsová V
    Zentralbl Bakteriol; 1997 Nov; 286(4):449-55. PubMed ID: 9440193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of ceftazidime on enterobacteria and Pseudomonas producers of beta-lactamases].
    Chabbert YA; Derlot E; Courvalin P
    Pathol Biol (Paris); 1985 Sep; 33(7):758-63. PubMed ID: 3936006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of cefepime against ceftazidime- and cefotaxime-resistant gram-negative bacteria and its relationship to beta-lactamase levels.
    Fung-Tomc J; Dougherty TJ; DeOrio FJ; Simich-Jacobson V; Kessler RE
    Antimicrob Agents Chemother; 1989 Apr; 33(4):498-502. PubMed ID: 2499250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and epidemiology of extended-spectrum β-lactamase-producing Enterobacteriaceae isolates susceptible to third-generation cephalosporins or to aztreonam.
    Bert F; Bialek-Davenet S; Leflon-Guibout V; Noussair L; Nicolas-Chanoine MH
    Med Mal Infect; 2014 Feb; 44(2):76-8. PubMed ID: 24525113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reevaluation of Enterobacteriaceae MIC/disk diffusion zone diameter regression scattergrams for 9 beta-lactams: adjustments of breakpoints for strains producing extended spectrum beta-lactamases.
    Jones RN; Craig WA; Ambrose PG; Dudley MN; Pottumarthy S
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):235-46. PubMed ID: 16105568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activities of NXL104 combinations with ceftazidime and aztreonam against carbapenemase-Producing Enterobacteriaceae.
    Livermore DM; Mushtaq S; Warner M; Zhang J; Maharjan S; Doumith M; Woodford N
    Antimicrob Agents Chemother; 2011 Jan; 55(1):390-4. PubMed ID: 21041502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative activity of beta-lactam antibiotics against 'intrinsically' ticarcillin-resistant strains of Pseudomonas aeruginosa.
    Bert F; Bruneau B; Lambert-Zechovsky N; Branger C
    Chemotherapy; 1994; 40(3):183-7. PubMed ID: 8205936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global Dissemination of blaKPC into Bacterial Species beyond Klebsiella pneumoniae and In Vitro Susceptibility to Ceftazidime-Avibactam and Aztreonam-Avibactam.
    Kazmierczak KM; Biedenbach DJ; Hackel M; Rabine S; de Jonge BL; Bouchillon SK; Sahm DF; Bradford PA
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4490-500. PubMed ID: 27161636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI screening parameters for the detection of extended-spectrum β-lactamase production in clinical Enterobacteriaceae isolates.
    Polsfuss S; Bloemberg GV; Giger J; Meyer V; Hombach M
    J Antimicrob Chemother; 2012 Jan; 67(1):159-66. PubMed ID: 21972269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro antibacterial activity and beta-lactamase stability of meropenem].
    Poiată A; Tuchiluş C; Bădicuţ I; Buiuc D
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):589-94. PubMed ID: 14756067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of BRL 36650, a new penicillin.
    Van Landuyt HW; Lambert A; Boelaert J; Gordts B
    Antimicrob Agents Chemother; 1986 Feb; 29(2):362-6. PubMed ID: 3087281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.